Laboratory Corp. Is Maintained at Overweight by Morgan Stanley
Morgan Stanley Maintains Labcorp Holdings(LH.US) With Buy Rating, Raises Target Price to $270
Labcorp Holdings Analyst Ratings
BofA Securities Maintains Labcorp Holdings(LH.US) With Buy Rating, Raises Target Price to $271
Labcorp Holdings Analyst Ratings
Jefferies Maintains Labcorp Holdings(LH.US) With Buy Rating, Raises Target Price to $275
Baird Maintains Labcorp Holdings(LH.US) With Buy Rating, Cuts Target Price to $286
Baird Adjusts Price Target on Labcorp to $286 From $289, Keeps Outperform Rating
Evercore Maintains Labcorp Holdings(LH.US) With Hold Rating, Maintains Target Price $260
Mizuho Securities Maintains Labcorp Holdings(LH.US) With Buy Rating, Announces Target Price $264
Barclays Maintains Labcorp Holdings(LH.US) With Hold Rating, Maintains Target Price $249
Barclays Sticks to Their Hold Rating for Laboratory (LH)
Labcorp Holdings Analyst Ratings
HSBC Upgrades Labcorp Holdings(LH.US) to Buy Rating
HSBC Upgrades Labcorp to Buy, Price Target Is $270
Labcorp Holdings Analyst Ratings
Laboratory Corp. Is Maintained at Neutral by Piper Sandler
Piper Sandler Maintains Labcorp Holdings(LH.US) With Hold Rating, Raises Target Price to $240
Laboratory (LH) Receives a Hold From Piper Sandler
Barclays Adjusts Price Target on Labcorp to $249 From $234, Maintains Equalweight Rating